Neuronetics, Inc. (STIM)

Compare

2.2200

+0.5100

+(29.82%)

As of 2:52:07 PM EST. Market Open.

Neuronetics Provides Business Update and Issues 2025 Guidance

Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as of December 9, 2024Expects full year 2025 pro forma year-over-year revenue growth of 12% - 19%Expects to realize over $22 million in annualized cost synergies Expects to achieve cash flow breakeven in the third quarter of 2025 MALVERN, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced preliminary f

GlobeNewswire 6 hours ago

STIM
+29.82%
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting of inducement awards to a new employee as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by the Compensation Committee of the Company’s Board of Directors and were made as material inducements to the recipients’ employment with the Company. In all cases, vesting is subject to the recipient’s continued service with the Compan

GlobeNewswire 25 days ago

STIM
+29.82%
Neuronetics and Greenbrook TMS Announce Closing of Transaction

MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”, and together with Neuronetics, the “Combined Company”) today announced that they have successfully completed the previously announced transaction whereby Neuronetics acquired all of the issued and outstanding common shares of Greenbrook (the “Greenbrook Shares”) by way of a court-approved plan of arrangement under the Business Corpor

GlobeNewswire last month

STIM
+29.82%
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024. The Company is scheduled to present at 2:30pm Eastern Time the same day via webcast. A live audio webcast

GlobeNewswire last month

STIM
+29.82%
Neuronetics Third Quarter 2024 Earnings: Misses Expectations

Neuronetics ( NASDAQ:STIM ) Third Quarter 2024 Results Key Financial Results Revenue: US$18.5m (up 3.6% from 3Q 2023...

Simply Wall St. last month

STIM
+29.82%
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025

One thing we could say about the analysts on Neuronetics, Inc. ( NASDAQ:STIM ) - they aren't optimistic, having just...

Simply Wall St. last month

STIM
+29.82%
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know

It's shaping up to be a tough period for Neuronetics, Inc. ( NASDAQ:STIM ), which a week ago released some...

Simply Wall St. last month

STIM
+29.82%
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ...

Neuronetics Inc (STIM) reports a 4% revenue increase and improved gross margins, while navigating increased net losses and strategic realignments.

GuruFocus.com last month

STIM
+29.82%
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the "Stockholders Approve Acquisition of Greenbrook TMS" section, it should say that the Company expects to achieve cash flow breakeven by the third quarter of 2025, not the second. The corrected release follows: Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technol

GlobeNewswire last month

STIM
+29.82%
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of -26.09% and 3.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

STIM
+29.82%
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the third quarter of 2024. Third Quarter 2024 Highlights Third quarter 2024 revenue of $18.5 million, a 4% increase as compared to the

GlobeNewswire 2 months ago

STIM
+29.82%
Rave Restaurant Group And 2 Other Promising US Penny Stocks

As the U.S. stock market experiences a rise, buoyed by gains in the technology sector and investor focus on the upcoming presidential election, attention is also drawn to smaller investment opportunities. Though often considered a relic from past trading days, "penny stocks" continue to represent potential for significant returns when they are backed by strong financials. This article will explore three such penny stocks that stand out for their balance sheet strength and growth potential in...

Simply Wall St. 2 months ago

RAVE

STIM
+29.82%
HLVX
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release third quarter 2024 financial and operating results prior to market open on Tuesday, November 12, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. The con

GlobeNewswire 2 months ago

STIM
+29.82%
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Data selected for oral presentation reinforce previous findings on safety and efficacyMALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their participation at the American Academy of Child and Adolescent Psychiatry (AACAP) in Seattle, WA, from October 14th-19th, including an oral

GlobeNewswire 2 months ago

STIM
+29.82%
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior Court of Justice (Commercial List) (the "Court") has granted an interim order (the "Interim Order") in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Plan of Arrangement"), pursuant to which, subject to the satisfaction or waiver of all applicable conditions pre

PR Newswire 3 months ago

STIM
+29.82%
GBNHF
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Policy update increases access for millions covered by HCSC BlueCross BlueShield policiesMALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that Health Care Service Corporation (HCSC) has expanded access to TMS (transcranial magnetic stimulation) for adolescents 15 and older with major

GlobeNewswire 3 months ago

STIM
+29.82%
STIM Stock Likely to Gain From Updated TMS Coverage

Neuronetics announces that TMS coverage has been updated to reduce access barriers for patients with MDD. In line with this, BCBS and Louisiana Medicaid have expanded their TMS coverage.

Zacks 3 months ago

STIM
+29.82%
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with DepressionMALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that additional payors have updated their TMS (transcranial magnetic stimulation) coverage to reduce access barriers for patient

GlobeNewswire 3 months ago

STIM
+29.82%
NeuroStar® Releases Software Upgrades to Elevate Patient Care

Upgrades improve communication, streamline data management, and strengthen securityMALVERN, Pa., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced enhancements to its NeuroStar Advanced Therapy and proprietary TrakStar® patient data management software, introducing a range of new features aimed at i

GlobeNewswire 3 months ago

STIM
+29.82%
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of LivesMALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is proud to shine a light on the powerful stories shared through the NeuroStar Voices Portal in recognition of Suicide Prevention Month. Launched last year

GlobeNewswire 4 months ago

STIM
+29.82%

Performance Overview

Return	STIM	S&P 500
YTD	+50.00%	-1.49%
1-Year	-26.97%	+21.64%
3-Year	-46.51%	+23.11%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Neuronetics, Inc. (STIM)

Neuronetics Provides Business Update and Issues 2025 Guidance

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Neuronetics Third Quarter 2024 Earnings: Misses Expectations

Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025

Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ...

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Rave Restaurant Group And 2 Other Promising US Penny Stocks

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

STIM Stock Likely to Gain From Updated TMS Coverage

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

NeuroStar® Releases Software Upgrades to Elevate Patient Care

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Performance Overview